Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620036
Title:
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.
Authors:
Halpin, David M; Kerkhof, M.; Soriano, J.B.; Mikkelsen, H.; Price, D.B.
Abstract:
Management guidelines of chronic obstructive pulmonary disease (COPD) are mainly based on results of randomised controlled trials (RCTs), but some authors have suggested limited representativeness of patients included in these trials. No previous studies have applied the full range of selection criteria to a broad COPD patient population in a real-life setting.
Citation:
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy., 17 (1):120 Respir. Res.
Publisher:
BioMed Central
Journal:
Respiratory Research
Issue Date:
23-Sep-2016
URI:
http://hdl.handle.net/11287/620036
DOI:
10.1186/s12931-016-0433-5
PubMed ID:
27663386
Additional Links:
http://respiratory-research.biomedcentral.com/articles/10.1186/s12931-016-0433-5
Note:
This article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.
Type:
Journal Article; Randomized Controlled Trial
Language:
en
ISSN:
1465-993X
Appears in Collections:
Respiratory Medicine; 2016 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorHalpin, David Men
dc.contributor.authorKerkhof, M.en
dc.contributor.authorSoriano, J.B.en
dc.contributor.authorMikkelsen, H.en
dc.contributor.authorPrice, D.B.en
dc.date.accessioned2016-10-14T11:05:55Z-
dc.date.available2016-10-14T11:05:55Z-
dc.date.issued2016-09-23-
dc.identifier.citationEligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy., 17 (1):120 Respir. Res.en
dc.identifier.issn1465-993X-
dc.identifier.pmid27663386-
dc.identifier.doi10.1186/s12931-016-0433-5-
dc.identifier.urihttp://hdl.handle.net/11287/620036-
dc.description.abstractManagement guidelines of chronic obstructive pulmonary disease (COPD) are mainly based on results of randomised controlled trials (RCTs), but some authors have suggested limited representativeness of patients included in these trials. No previous studies have applied the full range of selection criteria to a broad COPD patient population in a real-life setting.en
dc.languageENG-
dc.language.isoenen
dc.publisherBioMed Centralen
dc.relation.urlhttp://respiratory-research.biomedcentral.com/articles/10.1186/s12931-016-0433-5en
dc.rightsArchived with thanks to Respiratory Research. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en
dc.subjectWessex Classification Subject Headings::Respiratory medicineen
dc.titleEligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.en
dc.typeJournal Articleen
dc.typeRandomized Controlled Trialen
dc.identifier.journalRespiratory Researchen
dc.description.noteThis article is freely available via Open Access. Click on the Additional Link above to access the full-text via the publisher's site.en
dc.type.versionPublisheden
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.